Researchers Identify Cancer Drugs as Potential Alzheimer's Treatment, Indicating New Hope for Patients
Researchers from the University of California, San Francisco, have identified two existing cancer drugs, letrozole and irinotecan, as potential treatments for Alzheimer's disease. These drugs, typically used for breast and colon cancer, were found to reverse some brain changes associated with Alzheimer's in mouse models. The study utilized computational tools to analyze gene expression changes caused by Alzheimer's and identified these drugs as candidates that could counteract these changes. The drugs were shown to reduce harmful tau protein clumps in the brain and improve learning and memory in mice. This discovery opens the possibility of repurposing these FDA-approved drugs for Alzheimer's treatment, potentially accelerating the timeline for clinical trials. 
